FDA approves new Moderna mRNA vaccine without bothering with independent advisers
The U.S. Food and Drug Administration has approved Moderna’s mRNA-1345 vaccine, which allegedly protects adults aged 60 and older from respiratory syncytial virus infection-caused lower respiratory tract disease. The agency’s breakthrough therapy designation approval for the drug, which will be …
Read More